Detalhe da pesquisa
1.
A multicentric randomized controlled phase III trial of adaptive and 18F-FDG-PET-guided dose-redistribution in locally advanced head and neck squamous cell carcinoma (ARTFORCE).
Radiother Oncol
; 196: 110281, 2024 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-38636708